Financial Fraud Case Settled After Nine Years of Legal Battle
A federal court case that dragged on for nine years finally ended in a settlement, with Nerium International agreeing to pay $10 million to resolve a bitter dispute with Nerium Skincare and its founder Jeff Olson.
The deal came together at the last possible moment. On July 26, 2018—just four days before trial—both parties informed the court they had reached an agreement. It marked the end of a marathon legal fight that began in 2015 when Nerium Skincare first sued Olson, accusing him of running what the company called "illegal financial schemes" that left Skincare underpaid.
The case had become a grind. Four separate mediation sessions failed to produce a resolution. The most recent attempt, held June 12th, went nowhere. Settlement talks continued to stall until June 22nd, with no agreement in sight. Then something shifted. A scheduled pretrial conference on June 26th appeared to light a fire under both sides, and within weeks they hammered out terms.
The settlement revealed the anatomy of a corporate buyout designed to end years of acrimony. Nerium International paid $6 million upfront on July 26th, with the remaining $4 million due over three years. The deal gave Nerium International full ownership of what had been disputed assets and resolved not just the U.S. case but also separate litigation pending in Hong Kong.
The agreement included a ten-month transition period during which Nerium Skincare continues supplying three key products: NeriumAD Night, NeriumAD Day, and NeriumAD Firm. After the transition ends, Nerium Skincare retains ownership of critical trademark and intellectual property rights and can develop new products independently.
The numbers tell the story of a relationship that had deteriorated completely. In the nine years between the initial 2015 filing and the July 2018 settlement, lawyers filed 567 documents in the case. That volume of paperwork represents countless depositions, motions, and arguments—the kind of legal warfare that bleeds both sides dry.
For Nerium International's executive team, the settlement meant one thing: moving forward. In a press release issued after the deal closed, company leadership emphasized they could now focus on business and protect their network of brand partners. The Hong Kong litigation settlement also cleared the way for the company to expand product offerings in that market.
Neither side disclosed details of the settlement immediately. Only when Nerium Biotechnology, Nerium Skincare's parent company, issued a follow-up press release on July 27th did the $10 million figure become public. That lag in transparency is typical in these cases—companies prefer to control the narrative rather than let courts and documents do it for them.
What remains unclear is whether the $10 million represents a victory or compromise for either party. Olson and Nerium Skincare claimed they were owed money due to illegal schemes. Nerium International's decision to pay and move on suggests the company wanted closure more than vindication. After nine years of litigation, both sides probably just wanted their resources back.
🤖 Quick Answer
What was the settlement amount in the Nerium International case?Nerium International agreed to pay $10 million to resolve the dispute with Nerium Skincare and founder Jeff Olson, concluding a nine-year legal battle that began in 2015 when accusations of illegal financial schemes were first filed.
When was the settlement agreement reached?
The settlement was reached on July 26, 2018, just four days before the trial was scheduled to begin, following multiple failed mediation attempts over the course of the litigation.
What were the original accusations in the lawsuit?
Nerium Skincare accused Jeff Olson of operating illegal financial schemes that resulted in the company being underpaid, prompting the initial lawsuit filed in 2015.
How many mediation sessions occurred before settlement?
Four separate mediation sessions took place before reaching resolution, with the most recent unsuccessful attempt occurring on
🔗 Related Articles
- Eaconomy alleged fraud lawsuits voluntarily dismissed
- Nutra Pharma Corp settles MyNyloxin fraud with SEC
- MTI’s Liquidators and SARS settle tax dispute
- Herbalife to pay $15M settlement in Bostick class-action case
- Investview (Kuvera Global) fined $150,000 by CFTC
